Integrating non-drug treatments in early schizophrenia
暂无分享,去创建一个
[1] S. Lewis,et al. Duration of untreated psychosis and its relationship to clinical outcome , 2005, British Journal of Psychiatry.
[2] N. Tarrier,et al. Cognitive–behavioural therapy in first-episode and early schizophrenia , 2004, British Journal of Psychiatry.
[3] N. Tarrier,et al. A trial of two cognitive behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients , 1993, Social Psychiatry and Psychiatric Epidemiology.
[4] S. Lewis,et al. Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort , 2003, Schizophrenia Research.
[5] N. Tarrier,et al. Cognitive–behavioural therapy and motivational intervention for schizophrenia and substance misuse , 2003, British Journal of Psychiatry.
[6] T. McGlashan,et al. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome , 2003, Biological Psychiatry.
[7] R. Drake,et al. Insight and neurocognition in schizophrenia , 2003, Schizophrenia Research.
[8] B. Everitt,et al. Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia , 2003, Schizophrenia Research.
[9] J. Norrie,et al. Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy , 2003, Psychological Medicine.
[10] P. Buckley,et al. Treatment of the psychotic patient who is violent. , 2003, The Psychiatric clinics of North America.
[11] D. Streiner,et al. Family intervention for schizophrenia. , 2003, The Cochrane database of systematic reviews.
[12] Stephan Arndt,et al. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. , 2003, The American journal of psychiatry.
[13] J. Rey,et al. Cannabis and mental health , 2002, BMJ : British Medical Journal.
[14] Richie Poulton,et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study , 2002, BMJ : British Medical Journal.
[15] Glyn Lewis,et al. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study , 2002, BMJ : British Medical Journal.
[16] Hok Pan Yuen,et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. , 2002, Archives of general psychiatry.
[17] N. Tarrier,et al. Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: Acute-phase outcomes , 2002, British Journal of Psychiatry.
[18] T. Robbins,et al. Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: The West London Study , 2002, British Journal of Psychiatry.
[19] N. Tarrier,et al. NEW DEVELOPMENTS IN COGNITIVE-BEHAVIOURAL CASE FORMULATION. EPIDEMIOLOGICAL, SYSTEMIC AND SOCIAL CONTEXT: AN INTEGRATIVE APPROACH , 2002 .
[20] F. Guillem,et al. The dimensional symptom structure of schizophrenia and its association with temperament and character , 2002, Schizophrenia Research.
[21] A. Vergouwen,et al. Patient adherence with antidepressant treatment. , 2002, The British journal of psychiatry : the journal of mental science.
[22] S. Lawton-Smith. Patient adherence with antidepressant treatment , 2002, British Journal of Psychiatry.
[23] D. Kingdon,et al. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. , 2002, The British journal of psychiatry : the journal of mental science.
[24] P. McGorry,et al. Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia , 2002, Schizophrenia Research.
[25] W. Gaebel,et al. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies , 2002, Schizophrenia Research.
[26] T. Russell,et al. Further independent evidence for symptom-specific deficits in theory of mind in schizophrenia , 2002 .
[27] S. Leucht,et al. The effect of family interventions on relapse and rehospitalization in schizophrenia--a meta-analysis. , 2004, Schizophrenia bulletin.
[28] N. Tarrier,et al. Needs-based cognitive-behavioural family intervention for carers of patients suffering from schizophrenia: 12-month follow-up. , 2001 .
[29] N. Tarrier,et al. Needs‐based cognitive‐behavioural family intervention for carers of patients suffering from schizophrenia: 12‐month follow‐up , 2001, Acta psychiatrica Scandinavica.
[30] C. Barrowclough,et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. , 2001, The American journal of psychiatry.
[31] D. Linszen,et al. Social Functioning and the Course of Early-Onset Schizophrenia , 2001, British Journal of Psychiatry.
[32] R. Murray,et al. Comprehensive care of schizophrenia : a textbook of clinical management , 2001 .
[33] R. Drake,et al. Causes and consequences of duration of untreated psychosis in schizophrenia. , 2000, The British journal of psychiatry : the journal of mental science.
[34] S. Lawrie,et al. Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study , 2000, Psychological Medicine.
[35] I. Gottesman,et al. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. , 2000, The American journal of psychiatry.
[36] J. Os,et al. Medication adherence in psychosis: predictors and impact on outcome.A 2‐year follow‐up of first‐admitted subjects , 2000, Acta psychiatrica Scandinavica.
[37] Philip D. Harvey,et al. Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders. , 2000, The American journal of psychiatry.
[38] T. Sharma,et al. Neuropsychological functioning in first-episode psychosis — evidence of specific deficits , 2000, Schizophrenia Research.
[39] J. Lieberman,et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. , 2000, The American journal of psychiatry.
[40] C. Adams,et al. Influence of methodology on outcomes of randomised clozapine trials. , 2000, Pharmacopsychiatry.
[41] T. Sensky,et al. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. , 2000, Archives of general psychiatry.
[42] T. Sharma,et al. Neuropsychological functioning in first-episode psychosis — evidence for specific deficits , 2000, Schizophrenia Research.
[43] P. McGorry,et al. Does treatment delay in first-episode psychosis really matter? , 2000, Schizophrenia Research.
[44] R. Drake,et al. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. , 2000, Schizophrenia bulletin.
[45] E. Kuipers,et al. Family intervention in psychosis: who needs it? , 1999, Epidemiologia e Psichiatria Sociale.
[46] E. Johnstone,et al. Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS) , 1999, Psychological Medicine.
[47] Jane S. Paulsen,et al. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. , 1999, Archives of general psychiatry.
[48] K. Nuechterlein,et al. Neurobehavioral deficits at adolescence in children at risk for schizophrenia: The Jerusalem Infant Development Study. , 1999, Archives of general psychiatry.
[49] N. Tarrier,et al. Randomised controlled effectiveness trial of a needs-based psychosocial intervention service for carers of people with schizophrenia , 1999, British Journal of Psychiatry.
[50] B. Everitt,et al. The effects of neurocognitive remediation on executive processing in patients with schizophrenia. , 1999, Schizophrenia bulletin.
[51] N. Tarrier,et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia , 1998, BMJ.
[52] R. Rosenheck,et al. Does participation in psychosocial treatment augment the benefit of clozapine? Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. , 1998, Archives of general psychiatry.
[53] J. Hooley,et al. Expressed emotion and psychiatric relapse: a meta-analysis. , 1998, Archives of general psychiatry.
[54] S. Kapur,et al. Pharmacotherapy of first-episode schizophrenia , 1998, British Journal of Psychiatry.
[55] G. Kirov,et al. Randomised controlled trial of compliance therapy , 1998, British Journal of Psychiatry.
[56] T. Robbins,et al. Executive function in first-episode schizophrenia , 1998, Psychological Medicine.
[57] B. Rund,et al. A review of longitudinal studies of cognitive functions in schizophrenia patients. , 1998, Schizophrenia bulletin.
[58] Susan Cooley,et al. Three-Year Trials of Personal Therapy Among Schizophrenic Patients Living With or Independent of Family, I: Description of Study and Effects on Relapse Rates , 1997 .
[59] J. Waddington,et al. Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia , 1997, Psychological Medicine.
[60] G. Hogarty,et al. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. , 1997, The American journal of psychiatry.
[61] G. Dunn,et al. London–East Anglia randomised controlled trial of cognitive–behavioural therapy for psychosis , 1997, British Journal of Psychiatry.
[62] G. Hogarty,et al. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. , 1997, The American journal of psychiatry.
[63] M. Goldstein. Psycho-education and family treatment related to the phase of a psychotic disorder , 1996, International clinical psychopharmacology.
[64] Michael F. Green,et al. What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.
[65] P. Hayward,et al. Compliance therapy in psychotic patients: randomised controlled trial , 1996, BMJ.
[66] R. Dushay,et al. Multiple-family groups and psychoeducation in the treatment of schizophrenia. , 1994, Archives of general psychiatry.
[67] P. Dingemans,et al. Cannabis abuse and the course of recent onset schizophrenic disorders , 1993, Schizophrenia Research.
[68] J. Lieberman,et al. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. , 1992, Schizophrenia bulletin.
[69] H. Berenbaum,et al. Psychodynamic treatment of schizophrenia: is there a future? , 1990, Psychological Medicine.
[70] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[71] J. Leff,et al. The Influence of Family and Social Factors on the Course of Psychiatric Illness , 1976, British Journal of Psychiatry.